OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Late effects of cancer treatment: consequences for long-term brain cancer survivors
Montse Alemany, Roser Velasco, Marta Simó, et al.
Neuro-Oncology Practice (2020) Vol. 8, Iss. 1, pp. 18-30
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
Elisabete Cruz Da Silva, Marie-Cécile Mercier, Nelly Étienne-Selloum, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1795-1795
Open Access | Times Cited: 96

Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma
Vishwanath Kurawattimath, Barnabas Wilson, K. Geetha
OpenNano (2023) Vol. 10, pp. 100128-100128
Open Access | Times Cited: 23

An attention-fused architecture for brain tumor diagnosis
Arash Hekmat, Zuping Zhang, Saif Ur Rehman Khan, et al.
Biomedical Signal Processing and Control (2024) Vol. 101, pp. 107221-107221
Closed Access | Times Cited: 8

FLASH Radiotherapy
Heather R. Manring, Jessica L. Fleming, Wei Meng, et al.
Hematology/Oncology Clinics of North America (2025)
Closed Access | Times Cited: 1

Quantum dots: The cutting-edge nanotheranostics in brain cancer management
Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 698-715
Closed Access | Times Cited: 36

Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview
Giuseppe Lombardi, Pietro Luigi Poliani, Renzo Manara, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3646-3646
Open Access | Times Cited: 28

Mapping glioma’s impact on cognition: Insights from macrostructure, microstructure, and beyond
Núria Cayuela, Cristina Izquierdo, Lucía Vaquero, et al.
Neuro-Oncology Advances (2025) Vol. 7, Iss. 1
Open Access

Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis
Obada Alhalabi, Philip Dao Trong, Manuel Kaes, et al.
Journal of Neuro-Oncology (2024) Vol. 167, Iss. 2, pp. 245-255
Open Access | Times Cited: 4

Misdiagnosis and underdiagnosis of glioma: Systematic review
Dariya Ilchenko, Wolfgang Emanuel Zürrer, Amelia Elaine Cannon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States
Corey Neff, Mackenzie Price, Gino Cioffi, et al.
Cancer (2023) Vol. 129, Iss. 16, pp. 2514-2521
Closed Access | Times Cited: 8

Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Kirsi J. Rautajoki, Serafiina Jaatinen, Anja Hartewig, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 7

Modeling brain and neural crest neoplasms with human pluripotent stem cells
Cedar Schloo, Lena M. Kutscher
Neuro-Oncology (2023) Vol. 25, Iss. 7, pp. 1225-1235
Open Access | Times Cited: 5

Neurological side effects of radiation therapy
J. Jacob, L. Feuvret, Antoine Simon, et al.
Neurological Sciences (2022) Vol. 43, Iss. 4, pp. 2363-2374
Closed Access | Times Cited: 5

Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies
Vassilis Genoud, Denis Migliorini
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3493-3493
Open Access | Times Cited: 7

Chronic aphasias after left-hemisphere resective surgery
Greig I. de Zubicaray, Sonia Brownsett, David A. Copland, et al.
Brain and Language (2023) Vol. 239, pp. 105244-105244
Open Access | Times Cited: 2

Total Antioxidant Potential, Total Phenolic Profile and Cytotoxic Activity Against Brain Cancer: Melocan and Galdirik
Diaa Al Yassine, Nourhane El Massri, Günnur Demircan, et al.
Food Technology and Biotechnology (2023) Vol. 61, Iss. 4, pp. 475-484
Open Access | Times Cited: 2

Medication Burden Among Pediatric Cancer Survivors: Analysis of a Population-Wide Electronic Database in Hong Kong
Celeste L. Y. Ewig, Ka Ho Hui, Samantha Lai‐Ka Lee, et al.
JNCI Cancer Spectrum (2022) Vol. 6, Iss. 5
Open Access | Times Cited: 3

Symptom experience and symptom distress in patients with malignant brain tumor treated with proton therapy: A five-year follow-up study
Kristin Kunni, Ulrica Langegård, Emma Ohlsson‐Nevo, et al.
Technical Innovations & Patient Support in Radiation Oncology (2024) Vol. 31, pp. 100269-100269
Open Access

Page 1 - Next Page

Scroll to top